{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:49:26Z","timestamp":1787021366795,"version":"build-2736575974"},"reference-count":27,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,11,27]]},"DOI":"10.1248\/bpb.b24-00644","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:37:56Z","timestamp":1732642676000},"page":"1937-1945","source":"Crossref","is-referenced-by-count":4,"title":["Structurally Distinct Nurr1 Ligands Exhibit Different Pharmacological Characteristics in Regulating Inflammatory Responses of Microglial BV-2 Cells"],"prefix":"10.1248","volume":"47","author":[{"given":"Riko","family":"Nakanishi","sequence":"first","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, School of Pharmacy, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kurauchi","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kotani","sequence":"additional","affiliation":[{"name":"Global Center for Natural Resources Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Hitora-Imamura","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Seki","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University"},{"name":"Department of Pharmacology, School of Pharmacy, Himeji Dokkyo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Katsuki","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Law SW, Conneely OM, DeMayo FJ, O\u2019Malley BW. Identification of a new brain-specific transcription factor, NURR1. <i>Mol. Endocrinol.<\/i>, <b>6<\/b>, 2129\u20132135 (1992).","DOI":"10.1210\/mend.6.12.1491694"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Jakaria M, Haque ME, Cho DY, Azam S, Kim IS, Choi DK. Molecular insights into NR4A2(Nurr1): an emerging target for neuroprotective therapy against neuroinflammation and neuronal cell death. <i>Mol. Neurobiol.<\/i>, <b>56<\/b>, 5799\u20135814 (2019).","DOI":"10.1007\/s12035-019-1487-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zetterstr\u00f6m RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. <i>Science<\/i>, <b>276<\/b>, 248\u2013250 (1997).","DOI":"10.1126\/science.276.5310.248"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CKA. Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. <i>Cell<\/i>, <b>137<\/b>, 47\u201359 (2009).","DOI":"10.1016\/j.cell.2009.01.038"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Wang Z, Benoit G, Liu J, Prasad S, Aarnisalo P, Liu X, Xu H, Walker NP, Perlmann T. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. <i>Nature<\/i>, <b>423<\/b>, 555\u2013560 (2003).","DOI":"10.1038\/nature01645"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Jang Y, Kim W, Leblanc P, Kim CH, Kim KS. Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1. <i>Exp. Mol. Med.<\/i>, <b>53<\/b>, 19\u201329 (2021).","DOI":"10.1038\/s12276-021-00555-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Willems S, Merk D. Medicinal chemistry and chemical biology of Nurr1 modulators: an emerging strategy in neurodegeneration. <i>J. Med. Chem.<\/i>, <b>65<\/b>, 9548\u20139563 (2022).","DOI":"10.1021\/acs.jmedchem.2c00585"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kim CH, Han BS, Moon J, Kim DJ, Shin J, Rajan S, Nguyen QT, Sohn M, Kim WG, Han M, Jeong I, Kim KS, Lee EH, Tu Y, Naffin-Olivos JL, Park CH, Ringe D, Yoon HS, Petsko GA, Kim KS. Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson\u2019s disease. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>112<\/b>, 8756\u20138761 (2015).","DOI":"10.1073\/pnas.1509742112"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bruning JM, Wang Y, Oltrabella F, Tian B, Kholodar SA, Liu H, Bhattacharya P, Guo S, Holton JM, Fletterick RJ, Jacobson MP, England PM. Covalent modification and regulation of the nuclear receptor Nurr1 by a dopamine metabolite. <i>Cell Chem. Biol.<\/i>, <b>26<\/b>, 674\u2013685.e6 (2019).","DOI":"10.1016\/j.chembiol.2019.02.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Rajan S, Jang Y, Kim CH, <i>et al.<\/i> PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function. <i>Nat. Chem. Biol.<\/i>, <b>16<\/b>, 876\u2013886 (2020).","DOI":"10.1038\/s41589-020-0553-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Li X, Tjalkens RB, Shrestha R, Safe S. Structure-dependent activation of gene expression by bis-indole and quinoline-derived activators of nuclear receptor 4A2. <i>Chem. Biol. Drug Des.<\/i>, <b>94<\/b>, 1711\u20131720 (2019).","DOI":"10.1111\/cbdd.13564"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Munoz-Tello P, Lin H, Khan P, de Vera IMS, Kamenecka TM, Kojetin DJ. Assessment of NR4A ligands that directly bind and modulate the orphan nuclear receptor Nurr1. <i>J. Med. Chem.<\/i>, <b>63<\/b>, 15639\u201315654 (2020).","DOI":"10.1021\/acs.jmedchem.0c00894"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Inamoto T, Papineni S, Chintharlapalli S, Cho SD, Safe S, Kamat AM. 1,1-Bis(3\u2032-indolyl)-1-(<i>p<\/i>-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth. <i>Mol. Cancer Ther.<\/i>, <b>7<\/b>, 3825\u20133833 (2008).","DOI":"10.1158\/1535-7163.MCT-08-0730"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) De Miranda BR, Popichak KA, Hammond SL, Jorgensen BA, Phillips AT, Safe S, Tjalkens RB. The Nurr1 activator 1,1-bis(3\u2032-indolyl)-1-(<i>p<\/i>-chlorophenyl)methane blocks inflammatory gene expression in BV-2 microglial cells by inhibiting nuclear factor \u03baB. <i>Mol. Pharmacol.<\/i>, <b>87<\/b>, 1021\u20131034 (2015).","DOI":"10.1124\/mol.114.095398"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Willems S, Ohrndorf J, Kilu W, Heering J, Merk D. Fragment-like chloroquinolineamines activate the orphan nuclear receptor Nurr1 and elucidate activation mechanisms. <i>J. Med. Chem.<\/i>, <b>64<\/b>, 2659\u20132668 (2021).","DOI":"10.1021\/acs.jmedchem.0c01779"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kinoshita K, Yoshimizu A, Ichihara Y, Ushida K, Kotani S, Kurauchi Y, Seki T, Katsuki HA. Nurr1 ligand C-DIM12 attenuates brain inflammation and improves functional recovery after intracerebral hemorrhage in mice. <i>Sci. Rep.<\/i>, <b>12<\/b>, 11009 (2022).","DOI":"10.1038\/s41598-022-15178-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Dulla YA, Kurauchi Y, Hisatsune A, Seki T, Shudo K, Katsuki H. Regulatory mechanisms of vitamin D<sub>3<\/sub> on production of nitric oxide and pro-inflammatory cytokines in microglial BV-2 cells. <i>Neurochem. Res.<\/i>, <b>41<\/b>, 2848\u20132858 (2016).","DOI":"10.1007\/s11064-016-2000-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Takaoka Y, Takahashi M, Kurauchi Y, Hisatsune A, Seki T, Shudo K, Katsuki H. Retinoic acid receptor agonist Am80 inhibits CXCL2 production from microglial BV-2 cells <i>via<\/i> attenuation of NF-\u03baB signaling. <i>Int. Immunopharmacol.<\/i>, <b>38<\/b>, 367\u2013376 (2016).","DOI":"10.1016\/j.intimp.2016.06.025"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME. Novel inhibitors of cytokine-induced I\u03baB\u03b1 phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects <i>in vivo.<\/i> <i>J. Biol. Chem.<\/i>, <b>272<\/b>, 21096\u201321103 (1997).","DOI":"10.1074\/jbc.272.34.21096"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shao QH, Yan WF, Zhang Z, Ma KL, Peng SY, Cao YL, Yuan YH, Chen NH. Nurr1: a vital participant in the TLR4-NF-\u03baB signal pathway stimulated by \u03b1-synuclein in BV-2 cells. <i>Neuropharmacology<\/i>, <b>144<\/b>, 388\u2013399 (2019).","DOI":"10.1016\/j.neuropharm.2018.04.008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kim W, Tripathi M, Kim C, Vardhineni S, Cha Y, Kandi SK, Feitosa M, Kholiya R, Sah E, Thakur A, Kim Y, Ko S, Bhatia K, Manohar S, Kong YB, Sindhu G, Kim YS, Cohen B, Rawat DS, Kim KS. An optimized Nurr1 agonist provides disease-modifying effects in Parkinson\u2019s disease models. <i>Nat. Commun.<\/i>, <b>14<\/b>, 4283 (2023).","DOI":"10.1038\/s41467-023-39970-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sai M, Hank EC, Tai HM, Kasch T, Lewandowski M, Vincendeau M, Marschner JA, Merk D. Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing. <i>Commun. Chem.<\/i>, <b>7<\/b>, 149 (2024).","DOI":"10.1038\/s42004-024-01224-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Xie X, Peng L, Zhu J, Zhou Y, Li L, Chen Y, Yu S, Zhao Y. miR-145-5p\/Nurr1\/TNF-\u03b1 signaling-induced microglia activation regulates neuron injury of acute cerebral ischemic\/reperfusion in rats. <i>Front. Mol. Neurosci.<\/i>, <b>10<\/b>, 383 (2017).","DOI":"10.3389\/fnmol.2017.00383"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yoon DH, Hong SM, Ko EJ, Jeon RO, Kim SY. Anti-neuroinflammatory effects of active compound SPA1413 <i>via<\/i> suppression of the MAPK and JAK\/STAT signaling pathways. <i>Biol. Pharm. Bull.<\/i>, <b>46<\/b>, 1517\u20131526 (2023).","DOI":"10.1248\/bpb.b23-00319"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Horvath RJ, Nutile-McMenemy N, Alkaitis MS, Deleo JA. Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. <i>J. Neurochem.<\/i>, <b>107<\/b>, 557\u2013569 (2008).","DOI":"10.1111\/j.1471-4159.2008.05633.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hashida R, Kawabata T. Structural perspective of NR4A nuclear receptor family and their potential endogenous ligands. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 580\u2013590 (2024).","DOI":"10.1248\/bpb.b23-00600"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kinoshita K, Matsumoto K, Kurauchi Y, Hisatsune A, Seki T, Katsuki HA. Nurr1 agonist amodiaquine attenuates inflammatory events and neurological deficits in a mouse model of intracerebral hemorrhage. <i>J. Neuroimmunol.<\/i>, <b>330<\/b>, 48\u201354 (2019).","DOI":"10.1016\/j.jneuroim.2019.02.010"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/11\/47_b24-00644\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T22:28:36Z","timestamp":1732919316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/11\/47_b24-00644\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00644","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"article-number":"b24-00644"}}